Bernard Faller

3.9k total citations · 1 hit paper
38 papers, 2.9k citations indexed

About

Bernard Faller is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Bernard Faller has authored 38 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Computational Theory and Mathematics. Recurrent topics in Bernard Faller's work include Drug Transport and Resistance Mechanisms (11 papers), Computational Drug Discovery Methods (11 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Bernard Faller is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Computational Drug Discovery Methods (11 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Bernard Faller collaborates with scholars based in Switzerland, United States and Sweden. Bernard Faller's co-authors include Alex Avdeef, Manfred Kansy, Kiyohiko Sugano, Peter Ertl, Stefanie Bendels, Li Di, Per Artursson, Gerhard F. Ecker, Hanspeter Nick and Holger Fischer and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Bernard Faller

38 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coexistence of passive and carrier-mediated processes in drug transport

2010 486 citations Kiyohiko Sugano, Manfred Kansy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard Faller Switzerland	24	1.0k	675	553	443	415	38	2.9k
Tycho Heimbach United States	28	1.1k 1.0×	618 0.9×	295 0.5×	336 0.8×	793 1.9×	70	3.4k
Giulia Caron Italy	33	1.6k 1.5×	624 0.9×	802 1.5×	681 1.5×	192 0.5×	118	3.0k
Gian Camenisch Switzerland	26	871 0.8×	915 1.4×	440 0.8×	278 0.6×	264 0.6×	56	2.5k
Katrin Palm Sweden	8	1.1k 1.1×	988 1.5×	619 1.1×	519 1.2×	698 1.7×	9	3.2k
Andreas G. Tzakos Greece	34	1.8k 1.7×	401 0.6×	271 0.5×	412 0.9×	157 0.4×	171	4.1k
Jarkko Rautio Finland	31	2.1k 2.0×	977 1.4×	265 0.5×	251 0.6×	617 1.5×	88	5.0k
Philip S. Burton United States	28	1.5k 1.4×	1.4k 2.0×	303 0.5×	371 0.8×	925 2.2×	49	3.5k
Siavoush Dastmalchi Iran	31	1.3k 1.3×	362 0.5×	258 0.5×	173 0.4×	255 0.6×	178	3.2k
Peter W. Swaan United States	44	2.9k 2.7×	2.2k 3.2×	686 1.2×	287 0.6×	499 1.2×	129	6.9k
Zsolt Bikádi Hungary	28	1.7k 1.6×	932 1.4×	286 0.5×	286 0.6×	86 0.2×	70	3.1k

Countries citing papers authored by Bernard Faller

Since Specialization

Citations

This map shows the geographic impact of Bernard Faller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Faller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Faller more than expected).

Fields of papers citing papers by Bernard Faller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Faller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Faller. The network helps show where Bernard Faller may publish in the future.

Co-authorship network of co-authors of Bernard Faller

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Faller. A scholar is included among the top collaborators of Bernard Faller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Faller. Bernard Faller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huth, Felix, et al.. (2024). Improving In Vitro–In Vivo Extrapolation of Clearance Using Rat Liver Microsomes for Highly Plasma Protein-Bound Molecules. Drug Metabolism and Disposition. 52(5). 345–354. 2 indexed citations

Huth, Felix, et al.. (2021). Predicting Oral Absorption for Compounds Outside the Rule of Five Property Space. Journal of Pharmaceutical Sciences. 110(6). 2562–2569. 19 indexed citations

Faller, Bernard, Susanne Winiwarter, George Chang, et al.. (2019). Prediction of fraction unbound in microsomal and hepatocyte incubations – a comparison of methods across industry data sets (by the IQ in silico ADME working group). The Novartis Repository (Novartis). 1 indexed citations

Winiwarter, Susanne, George Chang, Prashant Desai, et al.. (2019). Prediction of Fraction Unbound in Microsomal and Hepatocyte Incubations: A Comparison of Methods across Industry Datasets. Molecular Pharmaceutics. 16(9). 4077–4085. 28 indexed citations

Berben, Philippe, Annette Bauer‐Brandl, Martin Brandl, et al.. (2018). Drug permeability profiling using cell-free permeation tools: Overview and applications. European Journal of Pharmaceutical Sciences. 119. 219–233. 151 indexed citations

Gedeck, Peter, Yipin Lu, Suzanne Skolnik, et al.. (2015). Benefit of Retraining pK_a Models Studied Using Internally Measured Data. Journal of Chemical Information and Modeling. 55(7). 1449–1459. 12 indexed citations

Faller, Bernard, Giorgio Ottaviani, Peter Ertl, Giuliano Berellini, & Alan Collis. (2011). Evolution of the physicochemical properties of marketed drugs: can history foretell the future?. Drug Discovery Today. 16(21-22). 976–984. 35 indexed citations

Zimmerlin, Alfred, et al.. (2011). CYP3A Time-Dependent Inhibition Risk Assessment Validated with 400 Reference Drugs. Drug Metabolism and Disposition. 39(6). 1039–1046. 61 indexed citations

Ottaviani, Giorgio, et al.. (2010). What is modulating solubility in simulated intestinal fluids?. European Journal of Pharmaceutical Sciences. 41(3-4). 452–457. 86 indexed citations

10.

Faller, Bernard, et al.. (2008). Metabolic Soft Spot Identification and Compound Optimization in Early Discovery Phases Using MetaSite and LC-MS/MS Validation. Journal of Medicinal Chemistry. 52(2). 329–335. 77 indexed citations

11.

Faller, Bernard. (2008). Artificial Membrane Assays to Assess Permeability. Current Drug Metabolism. 9(9). 886–892. 72 indexed citations

12.

Azzaoui, Khalil, Jacques Hamon, Bernard Faller, et al.. (2007). Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data. ChemMedChem. 2(6). 874–880. 127 indexed citations

13.

Avdeef, Alex, Stefanie Bendels, Lei Di, et al.. (2007). PAMPA—critical factors for better predictions of absorption. Journal of Pharmaceutical Sciences. 96(11). 2893–2909. 181 indexed citations

14.

Faller, Bernard & Peter Ertl. (2007). Computational approaches to determine drug solubility. Advanced Drug Delivery Reviews. 59(7). 533–545. 127 indexed citations

15.

Raduner, Stefan, Jian‐Zhong Chen, Xiang‐Qun Xie, et al.. (2006). Alkylamides from Echinacea Are a New Class of Cannabinomimetics. Journal of Biological Chemistry. 281(20). 14192–14206. 208 indexed citations

16.

Jacoby, Edgar, Ansgar Schuffenhauer, Khalil Azzaoui, et al.. (2004). Molecular Informatics as an Enabling in silico Technology Platform for Drug Discovery. CHIMIA International Journal for Chemistry. 58(9). 577–577. 3 indexed citations

17.

Nick, Hanspeter, Pierre Acklin, Bernard Faller, et al.. (2002). ICL670A: Preclinical Profile. Advances in experimental medicine and biology. 509. 185–203. 59 indexed citations

18.

Fox, Roy, Bernard Faller, Hanspeter Nick, et al.. (1999). In Vitro and In Situ Permeability of a 'Second Generation' Hydroxypyridinone Oral Iron Chelator: Correlation with Physico-Chemical Properties and Oral Activity. Pharmaceutical Research. 16(3). 434–440. 13 indexed citations

19.

Tomlinson, Brian, et al.. (1998). Caco-2 Cell Permeability of a New (Hydroxybenzyl)ethylenediamine Oral Iron Chelator: Correlation with Physicochemical Properties and Oral Activity. Journal of Pharmaceutical Sciences. 87(9). 1041–1045. 13 indexed citations

20.

Faller, Bernard, Yves Mély, Dominique Gérard, & Joseph G. Bieth. (1992). Heparin-induced conformational change and activation of mucus proteinase inhibitor. Biochemistry. 31(35). 8285–8290. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact